Advertisement

Formen der Vaskulitis

  • M. O. BeckerEmail author
  • B. Maurer
  • O. Distler
Leitthema
  • 57 Downloads

Zusammenfassung

Die Vaskulitiden sind (zumeist seltene) entzündliche Gefäßerkrankungen mit sehr heterogenem klinischem Erscheinungsbild. Sie können akut auftreten und lebensbedrohlich sein und erfordern häufig eine interdisziplinäre Zusammenarbeit bei Diagnostik und Therapie. Dieser Artikel soll einen Überblick über die verschiedenen Formen v. a. der systemischen Vaskulitiden und ihrer Klassifikation anhand der Nomenklatur der Vaskulitiden der internationalen Chapel-Hill-Konsensuskonferenz (CHCC) von 2012 geben. Dabei stehen klinische Erscheinungsformen und diagnostische Maßnahmen für die häufigsten Vaskulitiden großer, mittelgroßer und kleiner Gefäße im Mittelpunkt.

Schlüsselwörter

Systemische Vaskulitis Klassifikation Diagnostik ANCA-assoziierte Vaskulitis Arteriitis 

Types of vasculitis

Abstract

Vasculitides are (mostly rare) inflammatory diseases of blood vessels with very heterogeneous clinical symptoms. They can manifest suddenly and be potentially life-threatening and frequently necessitate an interdisciplinary cooperation for diagnostics and treatment. This article reviews the various forms and in particular systemic vasculitides and the nomenclature according to the 2012 International Chapel Hill Consensus Conference (CHCC) classification. The review focuses on clinical manifestations and diagnostic procedures for the more frequent forms of large, medium and small vessel vasculitis.

Keywords

Systemic vasculitis Classification Diagnosis ANCA-associated vasculitis Arteritis 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

M. O. Becker, B. Maurer und O. Distler geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11CrossRefGoogle Scholar
  2. 2.
    Holl-Ulrich K (2013) Vasculitis. New nomenclature of the Chapel Hill consensus conference 2012. Pathologe 34:569–579CrossRefGoogle Scholar
  3. 3.
    Baretton GB, Kirkpatrick CJ (2012) Vaskulitis. In: Böcker W, Denk H, Heitz PU, Höfler G, Kreipe H, Moch H (Hrsg) Pathologie. 5. Auflage. Elsevier Urban & Fischer, MünchenGoogle Scholar
  4. 4.
    Grayson PC, Maksimowicz-McKinnon K, Clark TM et al (2012) Distribution of arterial lesions in Takayasu’s arteritis and giant cell arteritis. Ann Rheum Dis 71:1329–1334CrossRefGoogle Scholar
  5. 5.
    Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88:221–226CrossRefGoogle Scholar
  6. 6.
    Keser G, Aksu K (2018) Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int.  https://doi.org/10.1007/s00296-018-4157-3 CrossRefPubMedGoogle Scholar
  7. 7.
    Tombetti E, Mason JC (2018) Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology (Oxf).  https://doi.org/10.1093/rheumatology/key040 CrossRefGoogle Scholar
  8. 8.
    Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 13:578–592CrossRefGoogle Scholar
  9. 9.
    Mason JC (2010) Takayasu arteritis – advances in diagnosis and management. Nat Rev Rheumatol 6:406–415CrossRefGoogle Scholar
  10. 10.
    Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806CrossRefGoogle Scholar
  11. 11.
    Mathew AJ, Goel R, Kumar S, Danda D (2016) Childhood-onset Takayasu arteritis: an update. Int J Rheum Dis 19:116–126CrossRefGoogle Scholar
  12. 12.
    Keser G, Aksu K, Direskeneli H (2018) Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology (Oxf) 57:784–790CrossRefGoogle Scholar
  13. 13.
    Dejaco C, Ramiro S, Duftner C et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77:636–643CrossRefGoogle Scholar
  14. 14.
    Luqmani R, Lee E, Singh S et al (2016) The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 20:1–238CrossRefGoogle Scholar
  15. 15.
    Monti S, Floris A, Ponte CB et al (2018) The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice. Rheumatology (Oxf) 57:112–119CrossRefGoogle Scholar
  16. 16.
    Czihal M, Lottspeich C, Hoffmann U (2017) Ultrasound imaging in the diagnosis of large vessel vasculitis. Vasa 46:241–253CrossRefGoogle Scholar
  17. 17.
    Vaglio A, Salvarani C, Buzio C (2006) Retroperitoneal fibrosis. Lancet 367:241–251CrossRefGoogle Scholar
  18. 18.
    Gornik HL, Creager MA (2008) Aortitis. Circulation 117:3039–3051CrossRefGoogle Scholar
  19. 19.
    Foote EA, Postier RG, Greenfield RA, Bronze MS (2005) Infectious aortitis. Curr Treat Options Cardiovasc Med 7:89–97CrossRefGoogle Scholar
  20. 20.
    Neudorf U (2011) Kawasaki disease in children and adolescents. Z Rheumatol 70:838–843CrossRefGoogle Scholar
  21. 21.
    Schirmer JH, Moosig F (2018) Update: polyarteritis nodosa. Z Rheumatol 77:397–408CrossRefGoogle Scholar
  22. 22.
    Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefGoogle Scholar
  23. 23.
    Tunca M, Akar S, Onen F et al (2005) Familial Mediterranean Fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRefGoogle Scholar
  24. 24.
    Yalcinkaya F, Ozcakar ZB, Kasapcopur O et al (2007) Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr 151:675–678CrossRefGoogle Scholar
  25. 25.
    Navon Elkan P, Pierce SB, Segel R et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931CrossRefGoogle Scholar
  26. 26.
    Springer JM, Gierer SA, Jiang H et al (2018) Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol 9:1361CrossRefGoogle Scholar
  27. 27.
    Pagnoux C, Seror R, Henegar C et al (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616–626CrossRefGoogle Scholar
  28. 28.
    Micheroli R, Distler O (2018) Polyarteritis nodosa. Rheumatology 57:670.  https://doi.org/10.1093/rheumatology/kex327 CrossRefPubMedGoogle Scholar
  29. 29.
    Csernok E (2018) ANCA-associated vasculitis: recent methodological advances for ANCA detection. Dtsch Med Wochenschr 143:499–502CrossRefGoogle Scholar
  30. 30.
    Hellmich B (2017) Current guidelines on ANCA-associated vasculitides : common features and differences. Z Rheumatol 76:133–142CrossRefGoogle Scholar
  31. 31.
    Holle JU, Gross WL, Latza U et al (2011) Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257–266CrossRefGoogle Scholar
  32. 32.
    Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefGoogle Scholar
  33. 33.
    Comarmond C, Pagnoux C, Khellaf M et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65:270–281CrossRefGoogle Scholar
  34. 34.
    Hellmark T, Segelmark M (2014) Diagnosis and classification of Goodpasture’s disease (anti-GBM). J Autoimmun 48–49:108–112CrossRefGoogle Scholar
  35. 35.
    Gulati K, McAdoo SP (2018) Anti-glomerular basement membrane disease. Rheum Dis Clin North Am 44:651–673CrossRefGoogle Scholar
  36. 36.
    McAdoo SP, Tanna A, Hruskova Z et al (2017) Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92:693–702CrossRefGoogle Scholar
  37. 37.
    Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775–788CrossRefGoogle Scholar
  38. 38.
    Moiseev S, Luqmani R, Novikov P, Shevtsova T (2017) Cryofibrinogenaemia – a neglected disease. Rheumatology (Oxf) 56:1445–1451Google Scholar
  39. 39.
    Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M (2017) New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmun Rev 16:1246–1253CrossRefGoogle Scholar
  40. 40.
    Floege J, Feehally J (2013) Treatment of IgA nephropathy and Henoch-Schonlein nephritis. Nat Rev Nephrol 9:320–327CrossRefGoogle Scholar
  41. 41.
    Atisha-Fregoso Y, Hinojosa-Azaola A, Alcocer-Varela J (2013) Localized, single-organ vasculitis: clinical presentation and management. Clin Rheumatol 32:1–6CrossRefGoogle Scholar
  42. 42.
    Hernandez-Rodriguez J, Hoffman GS (2012) Updating single-organ vasculitis. Curr Opin Rheumatol 24:38–45CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für RheumatologieUniversitätsspital ZürichZürichSchweiz

Personalised recommendations